慧智基因 SOFIVA GENOMICS (6615) 114Q2 法說會簡報
Company Overview
- Company Name: 慧智基因 SOFIVA GENOMICS (Sofiva Genomics Co., Ltd.)
- Stock Code: 6615
- Event: 法人說明會 (Investor Conference)
- Date of Presentation: 114/06/25 (June 25, 2025 - ROC Calendar Year)
- Chairman: 蘇怡寧 (Yi-Ning Su, MD. Ph.D)
- Slogan: Details Make Differences
- Contact Information:
- Website: www.sofiva.com.tw
- Tel: +886-2-2382-6615
- Fax: +886-2-2382-6617
- Address: 台北市100中正區寶慶路27號 (No. 27, Baoqing Rd., Zhongzheng Dist., Taipei City 100)
Disclaimer
- 本資料除提供歷史信息外,部份內容若涉及未來展望的表述,因受到風險及不確定因素影響,實際結果與表述內容將可能明顯不同。投資人應自行判斷與控制風險。
Business Segments and Product/Service Offerings
3.1. Dual-Axis Development (雙主軸發展)
- 母胎兒醫學 (Maternal-Fetal and Pediatric Medicine)
- 癌症精準醫學 (Precision Oncology)
3.2. Gene Testing Product Lines (基因檢測產品線)
- 生殖醫學 (Reproductive)
- Unit: 人工生殖中心 (Assisted Reproductive Technology Center)
- Population: 試管嬰兒 (IVF babies), 胚胎檢測 (Embryo testing)
- Specific Tests:
- 胚胎著床前單基因檢測 PGT-M
- 胚胎著床前染色體篩檢 PGT-A
- 非侵入性胚胎著床前染色體篩檢 niPGT-A
- 產前-孕前 (Prenatal-Pre-pregnancy)
- Unit: 婦產科 (Obstetrics and Gynecology)
- Population: 備孕夫妻 (Couples preparing for pregnancy), 懷孕夫妻(胎兒) (Pregnant couples (fetus))
- Specific Tests:
- 非侵產前染色體篩檢 NIPS
- 全方位複合式晶片檢測 Array CGH
- 產前細胞染色體檢查
- 帶因篩檢 Carrier Scan:
- 脊髓性肌肉萎縮症基因檢測-SMN基因
- X染色體脆折症基因檢測-FMR1基因
- 海洋性貧血基因檢測-HBA及HBB基因
- 葉酸代謝基因檢測-MTHFR基因
- 新生兒 (Newborn)
- Unit: 小兒科、新生兒科 (Pediatrics, Neonatology)
- Population: 新生兒 (Newborns), 幼童 (Young children)
- Specific Tests:
- 新生兒基因篩檢 Baby Scan
- 感覺神經性聽損基因檢測
- 先天中樞性換氣不足症候群基因檢測
- 先天性巨細胞病毒感染檢測
- 異位性皮膚炎過敏基因檢測-FLG基因
- 癌症 (Cancer)
- Unit: 與癌症相關科別 (Cancer-related departments)
- Population: 所有族群 (All populations) (癌前、癌友) (Pre-cancer, Cancer patients)
- Specific Tests:
- 癌監控基因檢測 Cancer Monitor
- 癌症基因篩檢 Cancer Scan
- 癌風險基因檢測v1.0/v2.0
- 人類乳突病毒篩檢(HPV)
- 精準用藥 (Precision Medicine)
- Unit: 與癌症用藥、罕病用藥相關科別 (Departments related to cancer drugs, rare disease drugs)
- Population: 所有族群 (All populations)
- Specific Tests:
- BRCA1/2基因檢測
- HRD檢測
- CGP基因檢測
- 子宮內膜癌基因分型
- 攝護腺癌基因檢測
- 罕見疾病 (Rare Disease)
- Unit: 基因檢測需求單位 (Gene testing demand units)
- Population: 所有族群 (All populations)
- Specific Tests:
- 聽損基因檢測 v1.0/v2.0/v3.0
- 軟骨發育不全(侏儒症)
- 成骨發育不全(玻璃娃娃)
- 裘馨氏肌肉萎縮症
- 威爾森氏症
- 馬凡氏症候群
- 全外顯子定序基因檢測
Strategic Initiatives and Plans
4.1. NHI Reimbursement (健保給付)
- NGS Testing Reimbursement (符合NGS檢測給付):
- Scope: 超過十種檢測 符合各癌別健保給付條件
- Inclusion: 14類實體腫瘤 and 5類血液腫瘤
- Reimbursement Amounts:
- BRCA基因檢測: 給付10000元
- 小套組 (≤100基因): 給付20000元
- 大套組 (>100基因): 給付30000元
- Data Upload: NGS test results must be uploaded to the NHI Administration for future drug matching.
- Approved Tests: Details included for various panels and conditions.
4.2. Layout for Health Checkup Market (佈局健檢市場)
- Overall Strategy: 全方位精準健康
- Target Groups & Focus:
- 備孕 (Pre-pregnancy)
- 女性 (Women)
- 男性 (Men)
- 長者 (Elderly)
- Products for Health Checkup Market:
- Include various gene screening and cancer risk assessments.
4.3. Reproductive Market Trends (生殖市場趨勢)
- Trend: 高齡生育需求提升
- Data provided for maternal age distribution over the years.
Financial Highlights and Key Metrics
5.1. Summary Income Statement for Recent Three Years (單位: 新台幣仟元)
| 項目 (Item) | 111年 (2022) | 112年 (2023) | 113年 (2024) |
|---|---|---|---|
| 營業收入 (Operating Revenue) | 495,775 | 466,797 | 453,312 |
| 營業毛利 (Gross Profit) | 148,988 | 129,908 | 135,661 |
| 毛利率 (Gross Margin) | 30.05% | 27.83% | 29.93% |
| 營業利益 (Operating Income) | 3,787 | -15,882 | -3,373 |
| 營業外收入及支出 (Non-operating Income and Expenses) | 43,562 | 24,785 | 26,988 |
| 稅前淨利 (Profit Before Tax) | 47,349 | 8,903 | 23,615 |
| 本期淨利 (Net Profit for the Period) | 43,153 | 11,923 | 19,128 |
| 每股盈餘(元) (Earnings Per Share (NT$)) | 2.00 | 0.54 | 0.86 |
5.2. Operating Revenue for Recent 10 Quarters (單位: 新台幣仟元)
- Details for quarterly revenue over recent years.
5.3. Operating Revenue for Recent 6 Months (單位: 新台幣仟元)
- Recent operating revenues month by month.
5.4. Investment Performance (轉投資績效) - Investee: 禾馨股份有限公司 (Herhsing Co., Ltd.)
- Summary of investment performance over the last three years for the investee.
Key Charts, Graphs, and Data Points
6.1. NGS NHI Reimbursement - National Declaration Statistics
- Total Declarations: 1,019件
- Large Panel: 423件
- Small Panel: 577件
6.2. Cancer: Top Ten Causes of Death
- Statistics on cancer deaths published by year.
6.3. Health Checkup Market Size
- User statistics and service utilization rates by age groups.
6.4. Alzheimer's Disease Prevalence and APOE Risk
- Prevalence rates and risk assessments based on APOE genotype.
6.5. Maternal Age Distribution
- Percentages of mothers in specific age groups over the years.
6.6. PGT-A Demand Growth - Annual Treatment Cycles
- Annual treatment cycle data to illustrate demand growth.